New York State Common Retirement Fund
LBRX

New York State Common Retirement Fund’s LB Pharmaceuticals LBRX Stock Holding History

New York State Common Retirement Fund’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
9,400
+3,300
+54% +$96.9K ﹤0.01% 2204
2026
Q1 		$150K Buy
+6,100
New +$141K ﹤0.01% 2346

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

New York State Common Retirement Fund's LBRX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its LB Pharmaceuticals (LBRX) stake by 54% in Q2 2026, buying an estimated $96.9K and bringing the position to 9,400 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #2204.

New York State Common Retirement Fund first reported a position in LBRX in Q1 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • New York State Common Retirement Fund held 9,400 shares of LB Pharmaceuticals worth $305K as of Q2 2026.
  • New York State Common Retirement Fund bought 3,300 LB Pharmaceuticals shares in Q2 2026, an estimated $96.9K.
  • LB Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2204 holding.
  • New York State Common Retirement Fund first reported a position in LB Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.